4.01
price down icon8.03%   -0.35
pre-market  Vorhandelsmarkt:  3.90   -0.11   -2.74%
loading
Schlusskurs vom Vortag:
$4.36
Offen:
$4.35
24-Stunden-Volumen:
3.70M
Relative Volume:
0.60
Marktkapitalisierung:
$1.09B
Einnahmen:
$8.10M
Nettoeinkommen (Verlust:
$-92.72M
KGV:
-11.23
EPS:
-0.3571
Netto-Cashflow:
$-82.52M
1W Leistung:
+2.30%
1M Leistung:
-20.59%
6M Leistung:
+71.37%
1J Leistung:
+81.45%
1-Tages-Spanne:
Value
$3.98
$4.35
1-Wochen-Bereich:
Value
$3.6929
$4.495
52-Wochen-Spanne:
Value
$1.05
$5.5082

Taysha Gene Therapies Inc Stock (TSHA) Company Profile

Name
Firmenname
Taysha Gene Therapies Inc
Name
Telefon
(214) 612-0000
Name
Adresse
3000 PEGASUS PARK DRIVE, DALLAS
Name
Mitarbeiter
73
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
TSHA's Discussions on Twitter

Vergleichen Sie TSHA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TSHA
Taysha Gene Therapies Inc
4.01 1.19B 8.10M -92.72M -82.52M -0.3571
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
434.52 110.16B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
694.99 71.65B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.97 59.81B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
891.73 54.79B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
368.36 41.77B 4.98B 69.59M 525.67M 0.5197

Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-10-21 Eingeleitet Raymond James Strong Buy
2025-07-11 Eingeleitet BofA Securities Buy
2024-06-27 Eingeleitet BMO Capital Markets Outperform
2024-04-09 Eingeleitet Piper Sandler Overweight
2023-02-01 Herabstufung Jefferies Buy → Hold
2023-01-27 Herabstufung Morgan Stanley Overweight → Equal-Weight
2022-11-09 Herabstufung Goldman Buy → Neutral
2022-03-09 Eingeleitet Robert W. Baird Outperform
2022-03-01 Eingeleitet Wells Fargo Overweight
2022-02-18 Eingeleitet SMBC Nikko Outperform
2021-12-16 Eingeleitet Guggenheim Buy
2021-07-16 Eingeleitet Needham Buy
2021-06-24 Eingeleitet Truist Buy
2021-06-15 Eingeleitet BTIG Research Buy
2021-06-09 Eingeleitet Wedbush Outperform
2021-06-08 Eingeleitet JMP Securities Mkt Outperform
2021-05-19 Eingeleitet Cantor Fitzgerald Overweight
2021-05-11 Fortgesetzt Jefferies Buy
2021-02-24 Eingeleitet William Blair Outperform
2021-01-05 Eingeleitet Oppenheimer Outperform
2020-10-19 Eingeleitet Chardan Capital Markets Buy
2020-10-19 Eingeleitet Goldman Buy
2020-10-19 Eingeleitet Jefferies Buy
2020-10-19 Eingeleitet Morgan Stanley Overweight
Alle ansehen

Taysha Gene Therapies Inc Aktie (TSHA) Neueste Nachrichten

pulisher
04:35 AM

How Taysha Gene Therapies Inc. stock benefits from strong dollarJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - newser.com

04:35 AM
pulisher
03:38 AM

Is Taysha Gene Therapies Inc. stock near bottom after declineWeekly Risk Report & Consistent Profit Alerts - newser.com

03:38 AM
pulisher
Nov 13, 2025

Using Bollinger Bands to evaluate Taysha Gene Therapies Inc.2025 Valuation Update & Trade Opportunity Analysis Reports - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Will Taysha Gene Therapies Inc. stock recover after recent drop2025 Earnings Surprises & Fast Momentum Entry Tips - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Taysha Gene Therapies Experiences Revision in Its Stock Evaluation Amid Mixed Performance Metrics - Markets Mojo

Nov 13, 2025
pulisher
Nov 13, 2025

Short interest data insights for Taysha Gene Therapies Inc.2025 EndofYear Setup & High Conviction Trade Alerts - newser.com

Nov 13, 2025
pulisher
Nov 12, 2025

Custom watchlist performance reports with Taysha Gene Therapies Inc.July 2025 Price Swings & High Return Trade Guides - newser.com

Nov 12, 2025
pulisher
Nov 12, 2025

Can Taysha Gene Therapies Inc. hit a new high this monthJuly 2025 Catalysts & Weekly Momentum Picks - newser.com

Nov 12, 2025
pulisher
Nov 11, 2025

Commit To Purchase Taysha Gene Therapies At $2.50, Earn 24% Using Options - Nasdaq

Nov 11, 2025
pulisher
Nov 11, 2025

Detecting support and resistance levels for Taysha Gene Therapies Inc.2025 Key Highlights & High Return Stock Watch Alerts - newser.com

Nov 11, 2025
pulisher
Nov 10, 2025

Candlestick signals on Taysha Gene Therapies Inc. stock todayBuy Signal & Accurate Entry and Exit Point Alerts - newser.com

Nov 10, 2025
pulisher
Nov 09, 2025

Will breakout in Taysha Gene Therapies Inc. lead to full recoveryPortfolio Performance Report & Technical Pattern Based Signals - newser.com

Nov 09, 2025
pulisher
Nov 09, 2025

How institutional ownership impacts Taysha Gene Therapies Inc. stockWeekly Risk Report & Free Risk Controlled Daily Trade Plans - newser.com

Nov 09, 2025
pulisher
Nov 09, 2025

Published on: 2025-11-09 05:46:32 - newser.com

Nov 09, 2025
pulisher
Nov 07, 2025

Citizens Lifts Price Target for Taysha Gene Therapies (TSHA) - Insider Monkey

Nov 07, 2025
pulisher
Nov 07, 2025

Taysha Gene Therapies Hits Day Low at $3.97 Amid Price Pressure - Markets Mojo

Nov 07, 2025
pulisher
Nov 07, 2025

Taysha Gene Therapies Inc. (TSHA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 07, 2025
pulisher
Nov 07, 2025

Can momentum traders help lift Taysha Gene Therapies Inc.2025 Buyback Activity & Free Safe Capital Growth Stock Tips - newser.com

Nov 07, 2025
pulisher
Nov 06, 2025

Why Taysha Gene Therapies Inc. stock is rated strong buyPortfolio Value Report & Safe Entry Momentum Tips - newser.com

Nov 06, 2025

Finanzdaten der Taysha Gene Therapies Inc-Aktie (TSHA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Taysha Gene Therapies Inc-Aktie (TSHA) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Nagendran Sukumar
President and Head of R&D
Sep 10 '25
Option Exercise
0.70
41,150
28,760
1,206,439
Nagendran Sukumar
President and Head of R&D
Sep 10 '25
Sale
3.23
200,000
646,000
1,006,439
$39.73
price up icon 0.35%
$30.24
price down icon 0.75%
$105.41
price down icon 2.63%
$103.88
price down icon 7.00%
$190.96
price down icon 1.76%
biotechnology ONC
$368.36
price down icon 2.41%
Kapitalisierung:     |  Volumen (24h):